Ome-489 is a novel, first-in-class, orally administered small molecule inhibitor of casein kinase 1 delta (CK1). It is being developed for the treatment o...
Brant McCullough, a name synonymous with innovation and leadership in the realm of technology, has carved a niche for himself as an influential figure in ...